Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Stoke Therapeutics (STOK) Leases (2022 - 2025)

Stoke Therapeutics (STOK) has 4 years of Leases data on record, last reported at $3.7 million in Q3 2025.

  • For Q3 2025, Leases fell 24.76% year-over-year to $3.7 million; the TTM value through Sep 2025 reached $3.7 million, down 24.76%, while the annual FY2024 figure was $4.3 million, 5.98% up from the prior year.
  • Leases reached $3.7 million in Q3 2025 per STOK's latest filing, up from $3.2 million in the prior quarter.
  • Across five years, Leases topped out at $6.1 million in Q1 2024 and bottomed at $3.1 million in Q3 2023.
  • Average Leases over 4 years is $4.5 million, with a median of $4.3 million recorded in 2024.
  • Peak YoY movement for Leases: tumbled 41.76% in 2023, then surged 59.79% in 2024.
  • A 4-year view of Leases shows it stood at $4.8 million in 2022, then fell by 13.74% to $4.1 million in 2023, then increased by 5.98% to $4.3 million in 2024, then fell by 14.66% to $3.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Leases were $3.7 million in Q3 2025, $3.2 million in Q2 2025, and $3.8 million in Q1 2025.